FDA Import Refusal AEK-5306726-8/41/1 — CIPLA LTD
The FDA refused shipment AEK-5306726-8/41/1 from CIPLA LTD (India) on Aug 21, 2024. The refused product falls under Drugs and Biologics — TAMSULOSIN HCL (REGULATOR). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Aug 21, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65PDY03 TAMSULOSIN HCL (REGULATOR)
- Charges
- 118,3280,75